What does iTeos Therapeutics, Inc. do?

Jun 22 2025 07:20 PM IST
share
Share Via
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing immuno-oncology therapeutics. It has a market cap of $383.50 million and reported a net profit loss of $35 million as of March 2025.
Overview:
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of differentiated immuno-oncology therapeutics for patients, operating within the Pharmaceuticals & Biotechnology industry and categorized as a micro-cap company.

Financial Snapshot:
Most recent Net Profit: -35 Million (Quarterly Results - Mar 2025)
Market-cap: USD 383.50 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -0.92
Return on Equity: -23.22%
Price to Book: 0.68

Contact Details:
Address: 139 Main Street, CAMBRIDGE MA: 02142
Tel: 1 857 2044583
Fax: 1 302 6555049
Website: https://www.iteostherapeutics.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is iTeos Therapeutics, Inc. technically bullish or bearish?
Sep 20 2025 08:25 PM IST
share
Share Via
Is iTeos Therapeutics, Inc. overvalued or undervalued?
Jun 25 2025 09:35 AM IST
share
Share Via
Is iTeos Therapeutics, Inc. technically bullish or bearish?
Jun 25 2025 09:19 AM IST
share
Share Via
Who are in the management team of iTeos Therapeutics, Inc.?
Jun 22 2025 10:46 PM IST
share
Share Via
How big is iTeos Therapeutics, Inc.?
Jun 22 2025 06:29 PM IST
share
Share Via